These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Reported results||2005-001243-28||Study to determine the non inferiority of GROUP I (“high need”) compared to GROUP II (“low need”) concerning the efficacy of infliximab with respect to safety and tolerability in patients suffering fr...||2006-09-08||due-trials|
|Reported results||2005-003164-35||A multinational, Subsidiary Sponsored, Randomized, Open-Label Study Comparing Treatment with Either Pegylated Liposomal Doxorubicin or Capecitabine as First Line Chemotherapy for Metastatic Breast Can...||2010-10-28||due-trials|
|Reported results||2006-005234-21||A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid-Dependent Subjects.||2009-05-28||due-trials|
|Reported results||2006-005235-14||A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users||2009-12-10||due-trials|
|Completed, but no date, and reported results||2009-010065-23||Conventional Step-Up versus Infliximab Monotherapy in Patients with Active Moderate to Severe Ulcerative Colitis. A Randomized, Open Label, Prospective, Multicenter Study (Phase 3, Protocol No. P05553...||bad-data|